Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,5R,8S,11S,14S,17R,20S,23S,26R,29R,35R,38R)-26-((1H-indol-3-yl)methyl)-17,20,35-tris(2-aminoethyl)-14-benzyl-5-sec-butyl-11-(2-carboxyethyl)-23,29-bis(hydroxymethyl)-8,38-diisopropyl-2-methyl-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaazapentapentacontan-1-oic acid
ID: ALA3115932
PubChem CID: 76321583
Max Phase: Preclinical
Molecular Formula: C80H129N17O19
Molecular Weight: 1633.01
Molecule Type: Unknown
Associated Items: